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nald Del Pozo, Volker Lange, Dieter Jüngst, and Gus-
tav Paumgartner. Fibronectin in human gallbladder bile: 
cholesterol pronucleating and/or mucin " l i n k " protein? Am. 
J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G393-G400, 
1994.—Some biliary proteins (pronucleators) seem to be essen-
tial factors for cholesterol crystal formation and crystal growth 
in bile. A recent study suggests that fibronectin is such a 
pronucleator in bile. Fibronectin also seems to closely interact 
with intestinal mucin. Since biliary mucin plays an important 
role in gallstone formation, such an interaction in bile may be 
of relevance in cholesterol gallstone formation. To more 
clearly elucidate the role of fibronectin in cholesterol gallstone 
disease, we measured the concentration of fibronectin in 
native bile of cholesterol gallstone patients and checked its 
influence on the cholesterol nucleation time of model bile. We 
further looked for a molecular interaction between biliary 
fibronectin and gallbladder mucin. We found that fibronectin 
is present in gallbladder bile of gallstone patients in low 
concentrations (2.6 ± 1.2 μ§7ιτι1). Bile fibronectin did not 
interact with gallbladder mucin. Moreover, in a wide range of 
concentrations fibronectin had no influence on the nucleation 
time of model bile. We conclude that fibronectin does not seem 
to play a major role in cholesterol gallstone disease. 
biliary proteins; cholesterol gallstone disease 
I T is N O W W E L L A C C E P T E D that multiple factors are 
involved i n the development of cholesterol gallstones i n 
the human gallbladder (28). Cholesterol supersatura-
t ion alone does not explain the formation of stones. 
Measurement of "crystal detection t i m e " or "nucleation 
t i m e " (NT) allows a clear separation of bile samples 
from patients w i t h and without cholesterol gallstones, 
and i t , therefore, appears that cholesterol nucleation is a 
critical step i n the formation of cholesterol gallstones 
(16, 28). Bil iary proteins seem to play an important role 
i n the regulation of the nucleation process (10, 36). I n 
recent years, major efforts have been undertaken by 
different research groups to characterize biliary proteins 
that favor precipitation of cholesterol i n model bile 
solutions (3, 5, 14, 25), to understand the molecular 
mechanism of interaction between these proteins and 
biliary lipids (12, 22, 25), and to define the relative 
importance of different known pronucleating proteins 
(26). 
I n a recent study (7), i t has been suggested that 
fibronectin, a well-characterized multi functional extra­
cellular matr ix and plasma glycoprotein (33), is a choles­
terol pronucleating protein. The pronucleating effect of 
fibronectin on model bile was dose dependent in a range 
of concentrations found by the authors in native bile 
samples. I t was also found that the concentrations of 
biliary fibronectin were significantly higher i n patients 
w i t h cholesterol gallstones compared w i t h stone-free 
patients. However, no correlation between fibronectin 
concentrations and N T was found in the native bile 
samples. 
I t is now well accepted that mucin is an important 
contributor to cholesterol gallstone formation (21, 36). 
I n addition to its cholesterol pronucleating effect, the 
viscoelastic features of mucin seem to be relevant for its 
role i n lithogenesis. The high viscosity of mucin may 
increase the residence t ime of lithogenic bile i n the 
gallbladder lumen (21, 36). The integrity of the macro-
molecular structure of mucin is essential for its rheologi-
cal features. There have been major methodological 
difficulties i n characterizing the macromolecular struc­
ture of this complex, large, and densely glycosylated 
glycoprotein (38). One view holds that an integral low-
molecular-mass protein links mucin subunits to form a 
large polymer ( " w i n d m i l l " model). A " l i n k prote in" was 
isolated from purified human gallbladder mucin (29) but 
not from bovine gallbladder mucin (37). Slomiany et al. 
(35) have recently postulated that fibronectin closely 
interacts w i t h intestinal mucin. I t was shown that a 
concanavalin A (ConA)-binding fragment of fibronectin 
(118 kDa) is immunologically and chemically identical to 
the integral "118-kDa l ink prote in" component found in 
purified mucin in previous studies (8, 24, 29). 
The present study was designed to more clearly 
elucidate the role of fibronectin in cholesterol gallstone 
disease. We 1) measured the concentrations of fibronec­
t i n i n native bile of cholesterol gallstone patients, 2) 
defined the molecular mass and immunological status of 
fibronectin i n bile, 3) investigated the influence of 
fibronectin on the nucleation time of a supersaturated 
model bile, and 4) looked for a possible molecular 
interaction between bil iary fibronectin and gallbladder 
mucin. 
M A T E R I A L S A N D M E T H O D S 
Chemicals and reagents. Rabbit polyclonal anti-human 
fibronectin was obtained fron Calbiochem (San Diego, CA). 
The monoclonal anti-human fibronectin antibody was pur­
chased from Boehringer Mannheim (Mannheim, Germany). 
This antibody belongs to the immunoglobulin (Ig) G l subclass 
and reacts with human fibronectin and with proteolytic frag­
ments that bind to heparin (17, 30). Monoclonal anti-human 
gallbladder mucin antibodies (GBM 59) were generated in the 
laboratories of Dr. A. K. Groen (Amsterdam, Netherlands). 
This mouse monoclonal antibody belongs to the IgM class. It 
specifically reacts with human gallbladder mucin with no 
cross-reactivity to pig gastric mucin, bovine submaxillar mu­
cin, or ConA-binding biliary glycoproteins. The epitope recog­
nized is probably the core sequence of the mucin carbohydrate 
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chain. Sepharose 4B-C1 and Sepharose 2B were obtained from 
Pharmacia (Uppsala, Sweden). CsCl was purchased from 
Beckman Instruments (Palo Alto, CA). All other chemicals 
were of analytical grade and were obtained from either Sigma 
Chemical (St. Louis, MO) or Merck (Darmstadt, Germany). 
Bile collection. Gallbladder bile samples obtained from 10 
cholesterol gallstone patients undergoing elective laparoscopic 
cholecystectomy were included in the study. At the beginning 
of the operation, before any surgical manipulation of the 
gallbladder and under visual control, gallbladder bile was 
completely aspirated into a sterile syringe by transcutaneous 
puncture with a 14-gauge needle. The samples were mixed 
with proteinase inhibitors phenylmethylsulfonyl fluoride, 
EDTA, iV-ethylmaleimide, and NaN 3 at final concentrations of 
1 mM, 5 mM, 10 mM, and 0.02%, respectively. The bile was 
immediately transported to the laboratory for further process­
ing. Absence of blood contamination in the samples was 
checked by microscopic inspection of bile sediment obtained by 
centrifugation of 2 ml bile at 18,000 g for 10 min. Blood-
contaminated bile samples {n = 2) were excluded from the 
study. Aliquots for biochemical determinations and fibronec-
tin quantification were flushed with N 2 and stored at -30°C 
and -80°C, respectively. All patients except one had functional 
gallbladders as defined by a total lipid concentration > 5 g/dl 
(9). Cholesterol stones were defined as stones with >50% 
cholesterol by weight and presence of multiple cholesterol 
monohydrate crystals at direct microscopic inspection of bile 
(18). After centrifugation of native bile at 18,000 g for 10 min 
at 37°C and subsequent micro filtration over 0.2 μιη sterile 
Minisart filter (Sartorius, Göttingen, Germany), the NT of bile 
was measured as described by Holan et al. (16). 
Gallbladder mucosal scrapings. In some of these patients 
(n = 7), the fresh closed gallbladder was also obtained. Within 
30 min, the gallbladder was opened and gently washed with 
0.9% NaCl (4°C). The epithelial surface was scraped with a 
glass slide to remove both epithelial cells and adherent mucus 
gel (37). The scraping was homogenized on ice in a Potter/ 
Elvehjem tube for 3 min in 10 mM phosphate buffer and 0.2 Μ 
NaCl, pH 7.4 [phosphate-buffered saline (PBS)J with protein­
ase inhibitors in concentrations as above. The homogenate 
was centrifuged at 30,000 g for 30 min at 4°C (70.1 Ti rotor, 
Beckman Instruments). The supernatant was stored at -30°C 
for later mucin extraction and purification as described below. 
Gel permeation chromatography of bile and purification of 
mucin. All bile samples were processed immediately after 
collection. Fractionation of biliary proteins and mucin extrac­
tion was performed according to the method of Pearson et al. 
(29), modified by Harvey et al. (13). All steps described below 
were performed under 4°C. Briefly, to remove bile acids, bile 
samples (5.0-7.0 ml) were dialyzed for 72 h against distilled 
water, containing 0.02% NaN 3 . The dialyzed bile was centri­
fuged at 30,000 g for 30 min, and the lipid pellet was discarded. 
The supernatant was chromatographed on a Sepharose 4B-C1 
column (80 x 2.6 cm) with PBS containing 0.02% NaN 3 as 
eluant, at a flow rate of 10 ml/h. Fractions of 5 ml were 
collected. The column was calibrated with standard molecular 
mass markers (range from 17 to 670 kDa; Sigma). The 
excluded fractions (F-I) containing the mucin-type glycopro­
teins were pooled and concentrated by reverse dialysis with 
60% solution of polyethylene glycol to ~ 5 ml. Further purifica­
tion of gallbladder mucin was performed by sequential (2x) 
CsCl-density gradient centrifugation (dgc; starting density = 
1.42 g/ml). Centrifugation was carried out in 6-ml polyallomer 
tubes at 4°C at 300,000 g for 6 h in a TV-865 Sorvall vertical 
rotor (Du Pont Instruments, Bad Homburg, Germany). Six 
fractions (0.8-1 ml) were collected by tube puncturing from 
the bottom (Gradient fractionator; Hoefer Scientific Instru­
ments, San Francisco, CA). Analysis of proteins and glycopro­
teins was performed as described below. Densities were deter­
mined by weighing the samples. No qualitative or quantitative 
differences were observed comparing this mode of CsCl-dgc 
with CsCl-dgc at 300,000 g for 24 h in a 70.1 Ti fixed angle 
rotor (Beckman Instruments) as described by Smith and 
LaMont (37) (data not shown). After dgc, the fractions contain­
ing mucin were pooled, extensively dialyzed against distilled 
water, lyophilized, and stored at -30°C for further analysis. 
The included fractions from gel chromatography were pooled 
in two separate fractions according to the apparent molecular 
mass [F-II < void volume (V0) > 200 kDa; F - I I I < 200 kDa], 
dialyzed for 48 h against distilled water, concentrated, lyophi­
lized, and stored as described above. 
Electrophoresis and protein blotting. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was carried 
out in 7% or 5-12% gradient separating gels with 3% stacking 
gel according to the method of Laemmli (20). Samples were 
run at a constant voltage of 50 mA in a Mighty Small II7CM 
vertical slab unit (Hoefer Scientific Instruments). Lyophilized 
pure gallbladder mucin was resuspended in 0.1 Μ tris(hydroxy-
methyDaminomethane (Tris) buffer, pH 7.5-2% SDS with or 
without 0.7 Μ 2-ß-mercaptoethanol (Laemmli's sample buffer 
for reduced and nonreduced conditions, respectively) and 
heated at 100°C for 5 min. Some mucin samples were reduced 
under more stringent conditions, i.e., by incubation with 
Laemmli's sample buffer for 40 h at 60°C as described by 
Pearson et al. (29). Aliquots of lyophilized samples from FII 
and F i l l and native bile samples were resuspended in 1 ml 
distilled water. Proteins were precipitated with 7% (vol/vol) 
trichloroacetic acid (TCA) and delipidated with cooled diethyl 
ether/ethanol 3:1 (vol/vol) (18). For analytical SDS-PAGE, 
the gels were stained for proteins with silver (15) and for 
glycoproteins with the periodic acid-Schiff (PAS) method (23). 
Electrophoretic transfer of the proteins to nitrocellulose sheets 
was carried out in a semidry-blotting system at 170 mA for 90 
min. To optimize the protein transfer, methanol content in all 
buffers was reduced to 10% and 0.05% SDS (wt/vol) included 
in the cathodic buffer. Satisfactory transfer was confirmed by 
silver and PAS staining of the blotted gels. The sheets were 
blocked by incubation for 2 h at 37°C with 50 mM Tris · HCl at 
pH 7.5 containing 0.1% Tween 20 and 0.2 Μ NaCl (TBS-
Tween 0.1%) (1). For fibronectin detection, the membranes 
were incubated for 2 h with rabbit polyclonal anti-human 
fibronectin (Calbiochem) or monoclonal anti-human heparin 
binding fibronectin fragment (clone 3E1; Boehringer Mann­
heim) antibodies in TBS-Tween 0.05% at a dilution of 1:750. 
To detect gallbladder mucin, monoclonal anti-human gallblad­
der mucin antibodies were used (GBM 59) at a dilution of 
1:3,000. The antibodies attached to the sheet were detected by 
incubation with alkaline phosphatase conjugated sheep anti-
rabbit (Calbiochem) or anti-mouse (Boehringer Mannheim) 
immunoglobulins, respectively, and the chromogenic sub­
strates for alkaline phosphatase (5-bromo-4 chloro-3-indolyl 
phosphate and nitroblue tetrazolium). 
Fibronectin quantification. The concentrations of fibronec­
tin in native bile samples were measured in the laboratory of 
Drs. Gressner and Kropf (Marburg, Germany) using a recently 
described highly sensitive and specific immunofluorometric 
assay (19). Briefly, aliquots of native bile stored at -80°C (for 
1-4 mo) were quickly thawed by gentle shaking at 37°C and 
diluted 1:10 and 1:100 (vol/vol) in assay buffer (50 mM 
Tris HCl, pH 7.5, 0.3 Μ KCl, 1 g/dl bovine serum albumin, 
and 0.05% NaN 3). Fibronectin quantification was carried out 
with the double antibody-based assay exactly as described 
before (19). Monoclonal anti-human fibronectin and polyclonal 
rabbit anti-human fibronectin were used as the coated and 
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detecting antibodies, respectively. Human-plasma fibronectin 
(Boehringer Mannheim, Germany) was used for standard 
curves. 
Determination of nucleation-influencing activity. Model bile 
was prepared according to Groen et al. (11). The final lipid 
concentrations were (in mM) 130 taurocholate, 13 cholesterol, 
and 30 phosphatidylcholine. The cholesterol saturation index 
was 1.2, and total lipid concentration (TLC) was 9 g/dl. The 
NT of the control varied from 6 to 9 days with different batches 
of model bile. Within one batch of model bile, the SD of NT was 
1 day (n = 40). A nucleation-influencing effect was considered 
significant when the difference in the nucleation time of the 
sample (NTs) with respect to the control (NTc) was two times 
the SD (2 days) (11). Human-plasma fibronectin (Calbiochem) 
checked for purity with gradient SDS-PAGE (5-12%) under 
reducing conditions was used for the additional experiments. 
Aliquots of fibronectin diluted in prefiltered PBS (0.2-μπι 
sterile Minisart filters) were added in duplicate to 500-μΐ 
prefiltered (0.2-μηι filters) model bile in 1.5-ml screw cup 
sterile Eppendorf tubes to yield final concentrations of 0.5, 1.2, 
10, 20, and 40 μg/ml (n = 4 for each concentration). These 
concentrations cover the range of fibronectin concentrations 
found by us and others (7, 41) in gallbladder bile. Equal 
aliquots of PBS but without fibronectin were added to model 
bile as controls. NT was determined as described by Holan et 
al. (16). To validate the model bile for the nucleation-
influencing activity assay, the effect of well characterized 
nucleation-promoting proteins was tested. Biliary pronucleat­
ing proteins were isolated from 500 μΐ lithogenic gallbladder 
bile by ConA Sepharose chromatography exactly as described 
before (11). The ConA-binding glycoprotein fraction dissolved 
in PBS and free of lipids was added to 500 μΐ of model bile to 
yield a final protein concentration of 200 μg/m\{n = 2). Equals 
volumes of PBS without protein were added to model bile as 
control. 
Chemical analysis. Biliary lipids in native and model bile 
were determined by standard techniques as previously de­
scribed (18). The cholesterol saturation index was determined 
using Carey's critical tables (6). Biliary proteins were mea­
sured after TCA precipitation and delipidation by the Lowry 
method modified by Jüngst et al. (18), using human serum 
albumin as standard. Protein in the eluted chromatographic 
and dgc fractions was estimated by the Bradford assay (2). 
Glycoprotein was estimated by the modified PAS method (23) 
with pig gastric mucin as standard (Sigma). 
Statistical analysis. Data are given as means ± SE. Associa-
tions between variables were searched with scatter plots and 
confirmed by linear regression analysis. 
R E S U L T S 
Fibronectin levels in bile. Gallbladder bile was ob-
tained from 10 cholesterol gallstone patients as de-
scribed i n M A T E R I A L S A N D M E T H O D S . Table 1 shows the bile 
composition and cholesterol N T for the samples studied. 
W i t h the use of the double antibody immunofluoromet-
ric assay w i t h a detection l imi t < 5 n g / m l (19), fibronec-
t i n was detected in bile of all the study patients. 
Concentrations were found to be 2.57 ± 1.16 μg/ml 
(mean ± SE; range 0.01-11 μg/ml). No significant 
correlation was observed between the levels of fibronec­
t i n i n gallbladder bile and the NT of the samples (r = 
-0 .29 , Ρ = 0.4) or any other bile component (TLC r = 
-0 .18 ; mucin r = -0 .25 ; total protein r = 0.22). 
Nucleation influencing activity. Since gallbladder fibro­
nectin was found to be intact antigenically and similar to 
Table 1. Characteristics of gallbladder bile samples 
Patient Protein, 
g / i 
Mucin, 
mg/ ml F N , μg/ml T L C , g/dl C S I ,
 c/c N T , days 
; 13.4 0.29 6.03 10.2 149 2 
2 31.3 0.14 1.55 20.4 95 11 
3 5.4 0.17 0.01 3.7 201 3 
4 19.7 0.14 11.0 10.9 110 2 
5 8.8 2.20 0.10 17.6 71 > 1 4 
6 12.0 0.15 0.28 8.9 85 5 
7 33.6 0.92 5.31 12.1 92 N D 
8 26.0 0.41 0.62 21.4 101 1 
9 9.6 0.25 0.39 12.8 102 2 
10 28.3 0.40 0.47 14.2 125 1 
Means ± S E 18.7 0.52 2.57 13.2 113 4.6 
±9.7 ±0 .63 ±3 .5 ±5 .1 ± 3 6 ±4 .7 
Concentrations of to ta l protein, mucin, fibronectin (FN), total lipids 
(TLC), cholesterol saturat ion index (CSD, and nucleation t ime (NT) of 
gallbladder samples collected from 10 patients w i t h cholesterol gall­
stones. 
plasma fibronectin (see Fig. 2), we decided to use plasma 
fibronectin to study the effect of fibronectin on the 
nucleation time of supersaturated model bile. A l l the 
previous studies on the pronucleating activity of fibronec­
t i n have also been performed w i t h plasma fibronectin (4, 
7). Fibronectin used showed a single protein band w i t h a 
molecular mass of 440 kDa on a gradient SDS-PAGE 
(5-12%) Under nonreducing conditions. As shown i n 
Table 2, fibronectin had no effect on the nucleation t ime 
of supersaturated model bile in the range of concentra­
tions found in gallbladder bile from gallstone patients 
(Table 1). In contrast, ConA-binding glycoprotein frac­
tion (200 μg/ml) isolated from lithogenic bile showed a 
significant nucleation-promoting activity w i t h an N T s / 
NTc ratio of 0.47 ± 0.02 at a concentration found i n 
native bile. 
Evaluation of structure and potential mucin associa­
tion of biliary fibronectin. Bile obtained from the gallblad­
ders of 10 patients w i t h cholesterol gallstones was 
fractionated on a Sepharose 4B-C1 column. Figure LA 
shows a representative chromatographic elution profile 
of a bile sample. A strongly PAS-positive glycoprotein 
fraction was excluded from the Sepharose 4B column 
together with lipids i n vesicular form (as assessed by the 
cloudy appearance of the tubes). This excluded fraction 
was termed F I . The included fractions were pooled i n 
F I I ( < V 0 > 200 kDa) and F i l l ( < 200 kDa). 
Table 2. Effect of FN on NT of model bile 
F N , μg/ml N T s / N T c 
0.5 0.9 ±0 .1 
1.2 1.1±0.3 
10.0 1.2±0.2 
20.0 1.1±0.1 
40.0 1.1±0.1 
Nucleation time (NT)- inf luencing activity of fibronectin (FN). Nucle­
ation-influencing activity is expressed as the rat io of N T of model bile 
w i t h F N (NTs) over the N T of model bile w i t h phosphate-buffered 
saline, i.e., control (NTc) (11). N T of the controls ranged from 6 to 9 
days w i t h a SD of 1 day. Pronucleating activity was defined as a rat io 
<0.73 and antinucleating activity as a ratio > 1.3 (11). Values are 
means ± SE of 4 experiments. 
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Fig. 1. Α: Sepharose 4B-C1 chromatography of predialyzed bile sample. 
Bile ( 4 -7 ml) was applied to the column (80 χ 2.6 cm) and eluted at a 
constant flow rate of 0.3 m l / m i n at 4°C w i t h PBS (10 m M phosphate 
buffer, 0.2 Μ NaCl, 0.02% N a N 3 , p H 7.4) as eluant. Fractions of 5 m l of 
the eluate were collected and screened for glycoprotein ( · ) by the 
method of Mantle and Allen (23) and for protein (A) by the method of 
Bradford (2). Excluded fractions rich in mucin type-glycoprotein were 
pooled i n F I ; the included fractions were separately pooled according 
to their molecular mass in F I I [ < void volume (V 0 ) > 200 kDaJ and 
F i l l ( < 2 0 0 kDa). Arrows indicate elution of molecular mass stan­
dards. B: 5 -12% gradient sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) of bi l iary proteins. Proteins from native 
bile (BG) and from the pooled eluted fractions after Sepharose 4B-C1 
chromatography (A; F I J I and I I I ) were precipitated w i t h lck tr ichloro­
acetic acid followed by ether/ethanol (3:1) delipidation. Samples were 
resuspended in Laemmli 's sample buffer under reducing conditions. A 
constant mass of 50 μg protein or glycoprotein (FI) was applied to each 
line. The gel was first stained for protein w i t h silver (a) and counter-
stained thereafter w i t h periodic acid-Schiff reagent (b). Migrat ion of 
molecular mass markers as indicated (kDa). 
Gradient SDS-PAGE w i t h silver stain and counter-
staining w i t h PAS (Fig. Iß) showed that high molecular 
mass glycoproteins (mucin) were the main constituents 
of F I . A high molecular mass polypeptide band is 
visualized at the top of the gel in native bile and F I ; this 
band stained intensely w i t h PAS. However, other weakly 
stained low molecular mass proteins coeluted together 
w i t h mucin in F I . Several polypeptide bands visualized 
w i t h silver and/or PAS stain were found in F I I and F i l l . 
As expected, the most predominant protein in F i l l had a 
molecular mass of 62 kDa and likely corresponded to 
albumin. 
Immunoblott ing of native biliary proteins and eluted 
protein fractions ( F I - I I I ) separated on SDS-PAGE u n -
der reducing and nonreducing conditions was carried 
out w i t h polyclonal and monoclonal anti-human fibronec-
t i n antibodies. Under nonreducing conditions ant i -
human fibronectin antibodies detected a weak single 
polypeptide band w i t h an apparent molecular mass of 
440 kDa i n native bile and i n F I I . This protein was 
identical to standard plasma fibronectin (data not 
shown). As expected, under reducing conditions the 
protein ran as an equimolar doublet w i t h a relative 
molecular mass of 220 kDa that comigrates w i t h the 
bands of plasma fibronectin (Fig. 2). Reactivity w i t h 
anti -human fibronectin antibody was not observed in 
the mucin-rich excluded fractions (FI) of any of the 10 
bile samples. 
The excluded fractions (FI) from the Sepharose 4B-C1 
chromatography were further purified by CsCl-dgc (2 x ) . 
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Fig. 2. Detection of fibronectin (FN) in native bile and in bi l iary 
protein fractions after Sepharose 4B-C1 chromatography (Fig. 1) using 
monoclonal ant i -human F N antibody. SDS-PAGE was carried out on a 
gel under reducing conditions. Western blots of standard plasma 
F N (lane FN, 0.1 μg), native bi l iary proteins (lane B, 300 μg), or 
proteins from the pooled eluted fractions after Sepharose 4B-C1 
chromatography (lanes F I , FII, Fill; 300 μg protein for each lane) 
were probed w i t h monoclonal ant i -human F N antibody. As shown, 
standard F N is recognize as a doublet band w i t h a molecular mass of 
220 kDa. A n identical doublet was shown in native gallbladder bile 
(lane B) and only in F I I after gel chromatography. None of the low-
molecular-mass proteins that comigrate w i t h mucin in F I (see Fig. IB) 
react w i t h ant i -human F N antibody (lane F I ) . 
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Because of the particular buoyant properties of mucin, 
this procedure separates highly glycosylated proteins 
(high-density fraction 1) from noncovalently bound 
proteins and lipids (lower density fractions 5-6; Fig. 3). 
Mucin recovered after dgc was free of low molecular 
mass proteins as assessed by gradient SDS-PAGE under 
nonreducing condition and silver stain. Integrity of the 
purified mucin was assessed by rechromatography on 
Sepharose 2B column. One mil l igram of purified gallblad­
der mucin was resuspended i n PBS and loaded on the 
column. One-hundred percent of the PAS-positive p u r i ­
fied glycoprotein remained in the excluded fractions. No 
low molecular mass break-down products were found 
(Fig. 4). Purified gallbladder mucin was then reduced by 
incubation w i t h 0.7 Μ mercaptoethanol Laemmli sample 
buffer for 40 h at 60°C and dialyzed for 24 h against 
PBS. To assess the degree of reduction achieved, re­
duced mucin was also fractionated on Sepharose 2B 
(Fig. 4). Over 85% of the total glycoprotein recovered 
was included and eluted w i t h a Κ ν^ of ~ 0.36, indicating 
a satisfactory reduction of disulfide bridges (29, 37). 
SDS-PAGE of pure bi l iary mucin under reducing condi­
tions (either boiled for 5 m i n or incubated at 60°C for 
40 h as described above) failed to show any mucin-
associated low molecular mass protein w i t h silver stain. 
A l l the low molecular mass proteins that coeluted w i t h 
mucin i n F I of the Sepharose 4B-C1 chromatography 
were recovered together w i t h lipids in the low-density 
fractions (fractions 5-6) after CsCl-dgc (Fig. 5). Further­
more, dot blots of purified soluble bil iary mucin, mucin 
extracted from gallbladder epithelial scraping, and pro­
teins recovered from the low-density fractions showed 
no immunoreactivity w i t h anti -human fibronectin ant i ­
bodies. I n contrast, a strongly positive immunoreactiv­
i ty of both types of samples was observed w i t h specific 
anti -human gallbladder mucin antibody (Fig. 6). 
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Fig. 3. Sequential CsCl-density gradient centrifugation of mucin-r ich 
void volume fractions. F I of Sepharose 4B chromatography (Fig. LA) 
was centrifuged in a vertical rotor at 300,000 g for 6 h. S tar t ing 
density was 1.42 g / m l (dotted line). After centrifugation, the tubes 
were fractionated into 6 equal fractions ( 0 . 8 - 1 ml) by punctur ing the 
bottom and were analyzed for glycoprotein ( · ) by the method of 
Mant le and Al len (23) and protein (A) by the method of Bradford (2). 
Inset, i n i t i a l CsCl-density gradient centrifugation (dgc) step. Duplicate 
samples of fractions 1 and 2 f rom the i n i t i a l dgc were di luted, brought 
to a density of 1.42 g / m l , and centrifuged once more under identical 
conditions (main graph). 
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Fig. 4. Sepharose 2B chromatography of 1 mg of puri f ied human 
gallbladder mucin before ( · ) and after reduction by incubation at 60°C 
for 40 h w i t h 0.7 Μ mercaptoethanol (O). The column (85 x 2.6 cm) 
was eluted at a constant flow rate of 10 m l / h , and fractions of 5 m l 
were collected. The eluant was 0.2 Μ NaCl, 0.02% N a N 3 , p H 7.4. 
Glycoprotein was estimated by the method of Mantle and Al len (23). 
Arrows indicate elution of molecular mass standards. 
D I S C U S S I O N 
Fibronectin, a well-characterized mult i functional ex­
tracellular matrix and plasma protein (33), has been 
implicated to be a pronucleating agent of cholesterol i n 
bile (7). I n addition, i t has recently been postulated that 
fibronectin closely interacts w i t h mucin (35). I n this 
context, the aim of the present study was to further 
define the possible role of fibronectin i n the pathogen­
esis of cholesterol gallstone disease. 
The concentrations of fibronectin i n human gallblad­
der bile from cholesterol gallstone patients measured 
w i t h an immunofluorometric assay (19) were i n the 
same range as the concentrations previously described 
for gallstone patients using other methods (7, 41). I n 
addition, we have found w i t h immunoblot analysis using 
specific polyclonal and monoclonal antibodies against 
plasma fibronectin that bile fibronectin was antigeni-
cally intact and showed a similar molecular mass to 
plasma fibronectin (i.e., a doublet w i t h 220 kDa under 
reducing conditions). No lower molecular mass proteo­
lytic fragments of fibronectin were found. 
The source of fibronectin in bile is unknown. Since 
hepatocytes appear to synthesize and secrete plasma-
type fibronectin (39), i t has been postulated that bil iary 
fibronectin is of hepatic origin (7). However, i n hepato­
cytes sorting and secretion of fibronectin into bile have 
not been demonstrated. Fibronectin is one of many 
plasma glycoproteins present i n bile (27). Its concentra­
t ion i n bile is < 1% of the normal plasma concentration 
(300 μg/ml) (40). This is i n the range of bile/plasma 
ratio measured for other plasma proteins (albumin, 
a 2-macroglobulin, and IgG) that use a hepatic paracellu-
lar pathway to reach the bile (27). Therefore, i n addition 
to active secretion plasma fibronectin may passively 
diffuse through hepatic paracellular shunts into bile. 
However, fibronectin may also reach gallbladder bile by 
diffusion across the gallbladder epithelium. Fibronectin 
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Fig. 5. Five to 12% gradient SDS-PAGE of purified gallbladder mucin. 
Bi l iary mucin was isolated by Sepharose 4B-C1 chromatography and 
puri f ied by sequential CsCl-dgc (Figs. 1A and 3). The high-density 
fractions 1 and 2 f rom the 2nd r u n were pooled, dialyzed, and 
lyophilized. Muc in was resuspended in Laemmli 's sample buffer. 
Reduction was carried out by incubation w i t h 0.7 Μ mercaptoethanol 
at 60°C for 40 h. Lane 1, 100 μg nonreduced mucin; lane 2, 100 μg 
reduced muc in ; lane 3, low-density fractions 5-6 f rom the 1st r u n of 
the CsCl-dgc. The gel was stained w i t h silver (a) and counterstained 
w i t h periodic acid-Schiff reagent (b). After reduction, both the polypep­
tide band at the top of the gel (a) and the single periodic acid-Schiff 
band (b) became broader. Reduction did not release any mucin " l i n k 
p r o t e i n . " The position of the molecular mass standards is shown at 
r i g h t (kDa). 
can be produced by macrophages, fibroblasts, polymor­
phonuclear leukocytes, and epithelial cells. Gallbladder 
inflammation is a frequent f inding i n gallstone patients. 
Biliary fibronectin appears to be higher in acute cholecys­
t i t i s than in chronic cholecystitis and stone-free patients 
(7, 41). Increased levels of fibronectin have been mea­
sured i n body fluids other than plasma as a consequence 
of epithelial damage and/or inflammation (19, 31, 34). 
We have observed that bil iary concentrations of fibronec­
t i n did not correlate to the total l ipid or bile salts 
content, i.e., bi l iary concentrations were independent of 
the degree of concentration of hepatic bile by the 
gallbladder. The absence of such a correlation points 
toward the gallbladder as the source of fibronectin i n 
gallbladder bile. Conceivably therefore, fibronectin may 
leak through a damaged gallbladder epithelium into bile. 
Further studies are needed to better define the origin of 
fibronectin i n bile. 
Fibronectin failed to accelerate cholesterol nucleation 
i n model bile i n the range of concentrations measured i n 
gallbladder bile of cholesterol gallstone patients (Table 
2). This finding is supported by a recent study of Bru i jn 
et al. (4) i n which plasma fibronectin used in concentra­
tions similar to i n our experiments had no effect on 
cholesterol crystal growth i n model bile. There are, 
however, major differences between both the latter 
study and our data and the study of Chijiiwa et al. (7) i n 
which a marked pronucleating activity of plasma fibro­
nectin was found. The reasons for this discrepancy are 
unclear. Methological differences i n the preparation of 
the model bile may at least i n part explain the different 
findings. We used a well-defined supersaturated model 
bile that has previously been shown to be a good in vitro 
model for cholesterol nucleation assays (11, 14, 25). 
Positive control assays using ConA-binding biliary pro­
teins exerted the expected pronucleating effect in this 
model bile. Chiji iwa et al. (7) used a relatively fast 
nucleating bile (4 days) w i t h a comparatively low sensi­
t iv i ty for pronucleating activity. 
Studies on the cholesterol pronucleating activity of 
fibronectin i n bile have all been performed using plasma 
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Fig. 6. Dot blot analysis of purified bi l iary mucin 1 2 3 4 1 2 3 
and muc in extracted from gallbladder epithelial 
scraping. Soluble bi l iary mucin and mucin from 
gallbladder epithelial scraping were extracted and 0.1 ~ 
puri f ied as described in M A T E R I A L A N D M E T H O D S . 
Standard plasma fibronectin (lane 1), purif ied . 
soluble b i l iary mucin (lane 2 ) , and mucin from 
epithelial scrapings (lane 3) were probed w i t h 
either monoclonal ant i -human fibronectin (A) or 
monoclonal ant i -human gallbladder mucin (B) an­
tibodies. Lane 4, low-density fraction from the 1st 
r u n of the CsCl-dgc step. Amount of protein (p.g) 
applied to each row of dots is show at r ight for 
mucin and low-density fractions proteins and at Λ c _ | H B Jgfe _ c;n 
left for f ibronectin. CSp 
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fibronectin. Chiji iwa et al. (7), B r u i j n et al. (4), and we 
have used plasma fibronectin because i t appears that 
fibronectin i n bile is identical to plasma fibronectin. To 
test this view, we have performed gel chromatography, 
SDS-PAGE, and Western blots on native bile. These 
experiments show identical immunoreactivity and iden-
tical molecular mass of bile and plasma fibronectin (Fig. 2). 
A t ight association between the " s t i cky" fibronectin 
and phospholipid vesicles has been reported (32). This 
observation appeared to support the view that fibronec-
t i n may exert pronucleating activity and may be the 
mechanism of its pronucleating effect i n bile (7). How-
ever, as we have recently shown (25), a t ight interaction 
of proteins w i t h bil iary vesicles does not necessarily 
implicate pronucleating activity of proteins. Indeed, i n 
this previous study only three of the six proteins bound 
to vesicles isolated from hepatic bile of cholesterol 
gallstone patients exerted pronucleating activity. For 
the present study, i t is of interest that fibronectin was 
not found to be bound to purified native bi l iary vesicles. 
Gallbladder mucin is known to be a pronucleator in 
model bile. I n addition, since i t is the major determinant 
of bile viscosity i t may profoundly influence gallbladder 
emptying and cholesterol crystal growth (21). The integ-
r i t y of the macromolecular structure of mucin is essen-
t ia l for these mucus functions. For years, i t has been 
postulated that mucin contains so-called integral l ink 
proteins that hold monomeric basic units together by 
covalent bonds to form the macrostructure of the large 
functionally active mucin (windmil l model) (38). I n 
intestinal mucin, the antigenically and chemical proper-
ties of a 118-kDa l ink protein appeared to be identical to 
a fibronectin fragment (35). A similar mucin- l ink pro-
tein has been previously postulated for gallbladder 
mucin (29). However, our gel chromatographic fraction-
ation studies i n combination w i t h SDS-PAGE (Fig. Iß) 
and immunoblott ing analysis (Figs. 2, 5, and 6) clearly 
show that fibronectin does not interact w i t h soluble 
bil iary mucin or mucin purified from gallbladder epithe-
l ial scrapings. Furthermore, under effective reducing 
conditions, purified gallbladder mucin did not release 
any other low molecular mass l i n k proteins as assessed 
by gradient SDS-PAGE w i t h silver stain. This observa-
tion is supported by elaborate studies of Smith and 
LaMont (37), which also failed to detect a mucin- l ink 
protein i n bovine gallbladder mucin. Low-molecular-
mass proteins (120-30 kDa) that coeluted w i t h mucin i n 
the V 0 fraction of gel chromatography (Fig. 1) were 
completely separated from mucin-type glycoproteins 
after a first or second r u n of CsCl-dgc (Figs. 3 and 5), 
showing that these proteins were not covalently bound 
to mucin. I t is therefore, quite conceivable that most of 
these low- molecular-mass proteins coelute i n the V 0 
fraction because of a close binding to bil iary vesicles and 
not to mucin (25). 
I n conclusion, fibronectin is present i n gallbladder bile 
of cholesterol gallstone patients i n concentrations simi-
lar to body fluids other than plasma. Bile fibronectin is 
antigenically intact and has a molecular mass similar to 
plasma fibronectin. I n a wide range of concentrations, 
fibronectin has no effect on the nucleation time of 
supersaturated model bile. Purified human gallbladder 
mucin does not interact w i t h biliary fibronectin nor does 
i t require an integral l ink protein to mainta in its 
macromolecular structure. Taken together, our data do 
not support a role of fibronectin in cholesterol gallstone 
disease. 
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